Aaron Royston
CIK: 0001727703
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Royston Aaron
Royston Aaron (SEC CIK 0001727703) files insider reports with the SEC as Director of Attovia Therapeutics, Inc. (ATTO) and Director of ACHIEVE LIFE SCIENCES, INC. (ACHV).
Signal8 holds 3 ownership filings by Royston Aaron (2 Form 3, 1 Form 4), filed between Apr 27, 2026 and Aug 4, 2026. Those filings report 2 transactions, the latest on Jul 27, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Royston Aaron's filings is in BOTHELL, WA.
Recent filings by Royston Aaron
- Jul 27, 2026: Grants or awards of ACHV derivative securities (2 lines, Form 4, code A).
Other insiders filing for Attovia Therapeutics, Inc. (ATTO)
- Fu Tao, President and CEO
- Chan Steven, Chief Financial Officer
- WALSH COLIN, Director
- GOLDMAN SACHS GROUP INC, Officer
- Deep Track Biotechnology Master Fund, Ltd., 10% Owner
- venBio Global Strategic Fund IV, L.P., 10% Owner